United States · Biotechnology startup

Leuko

Leuko Labs develops non-invasive white blood cell monitoring device.

Funding reportedLast round: Grant

BiotechnologyBoston, United States

What company datasets say Leuko raised

Funding, as reported

Reported in all$12Min dollars
Rounds9
Last roundGrant
Last round dateJul 2024
Investors listed10
SEC Form D$1.2M sold, 1 filing, last Feb 2019

Founders and team

From Leuko's own website: 5 on the team.

  • Amy SalzhauerBoard of Directors
  • Ganimete LamajSenior Human Factors Engineer & Quality Manager
  • Jose Antonio Pelaez EscobarComputer Vision and Machine Learning Engineer
  • Paul HartungIndependent Board Member
  • Ryan BenasuttiSenior Software Engineer

On 5 portfolio pages

Investors who name them

Each firm lists Leuko on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

Biotechnology in United States

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Leuko in front of investors. Or tell us what we have wrong.